Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma

Cisplatin is one of the most effective chemotherapeutic agents commonly used for several malignancies including oral squamous cell carcinoma (OSCC). Although cisplatin resistance is a major obstacle to effective treatment and is associated with poor prognosis of OSCC patients, the molecular mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Suenaga, Naoki, Kuramitsu, Mimi, Komure, Kanae, Kanemaru, Ayumi, Takano, Kanako, Ozeki, Kazuya, Nishimura, Yuka, Yoshida, Ryoji, Nakayama, Hideki, Shinriki, Satoru, Saito, Hideyuki, Jono, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829433/
https://www.ncbi.nlm.nih.gov/pubmed/31635163
http://dx.doi.org/10.3390/ijms20205194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829433/
https://www.ncbi.nlm.nih.gov/pubmed/31635163
http://dx.doi.org/10.3390/ijms20205194

Ejemplares similares